Evidence map›Paper›PMID 40373301›Full record

SynthesisJournal of medical Internet research2025

Challenges in Implementing Artificial Intelligence in Breast Cancer Screening Programs: Systematic Review and Framework for Safe Adoption.

Serene Goh, Rachel Sze Jen Goh, Bryan Chong, Qin Xiang Ng, Gerald Choon Huat Koh, Kee Yuan Ngiam, Mikael Hartman

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Serene GohDepartment of Surgery, National University Hospital, Singapore, Singapore.ORCID 0000-0003-4916-2142
Rachel Sze Jen GohYong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore.ORCID 0009-0007-1875-8257
Bryan ChongYong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore.ORCID 0000-0002-3565-7657
Qin Xiang NgSaw Swee Hock School of Public Health, National University Heart Centre Singapore, Singapore, Singapore.ORCID 0000-0001-8561-2513
Gerald Choon Huat KohSaw Swee Hock School of Public Health, National University Heart Centre Singapore, Singapore, Singapore.ORCID 0000-0002-6453-6897
Kee Yuan NgiamNational University Hospital Singapore, Singapore, Singapore.ORCID 0000-0001-5676-2520
Mikael HartmanNational University Hospital Singapore, Singapore, Singapore.ORCID 0000-0001-5726-9965

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundArtificial intelligence (AI) studies show promise in enhancing accuracy and efficiency in mammographic screening programs worldwide. However, its integration into clinical workflows faces several challenges, including unintended errors, the need for professional training, and ethical concerns. Notably, specific frameworks for AI imaging in breast cancer screening are still lacking.

objectiveThis study aims to identify the challenges associated with implementing AI in breast screening programs and to apply the Consolidated Framework for Implementation Research (CFIR) to discuss a practical governance framework for AI in this context.

methodsThree electronic databases (PubMed, Embase, and MEDLINE) were searched using combinations of the keywords "artificial intelligence," "regulation," "governance," "breast cancer," and "screening." Original studies evaluating AI in breast cancer detection or discussing challenges related to AI implementation in this setting were eligible for review. Findings were narratively synthesized and subsequently mapped directly onto the constructs within the CFIR.

resultsA total of 1240 results were retrieved, with 20 original studies ultimately included in this systematic review. The majority (n=19) focused on AI-enhanced mammography, while 1 addressed AI-enhanced ultrasound for women with dense breasts. Most studies originated from the United States (n=5) and the United Kingdom (n=4), with publication years ranging from 2019 to 2023. The quality of papers was rated as moderate to high. The key challenges identified were reproducibility, evidentiary standards, technological concerns, trust issues, as well as ethical, legal, societal concerns, and postadoption uncertainty. By aligning these findings with the CFIR constructs, action plans targeting the main challenges were incorporated into the framework, facilitating a structured approach to addressing these issues.

conclusionsThis systematic review identifies key challenges in implementing AI in breast cancer screening, emphasizing the need for consistency, robust evidentiary standards, technological advancements, user trust, ethical frameworks, legal safeguards, and societal benefits. These findings can serve as a blueprint for policy makers, clinicians, and AI developers to collaboratively advance AI adoption in breast cancer screening.

trial registrationPROSPERO CRD42024553889; https://tinyurl.com/mu4nwcxt.

Indexed as

Artificial IntelligenceBreast NeoplasmsEarly Detection of CancerFemaleHumansMammographyaccuracyAIapplicationapplicationsartificial intelligencebreast cancerbreast screeningcancer screeningdigital healthefficiencyimagingmammogrammammogramsmortalitypublic healthradiologyriskscreening

Identifiers

PMID40373301
PMCPMC12123233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.